Madison India Capital has sold 2.48 crore shares of Pine Labs at a slight premium in a block deal worth approximately ₹357 crore, marking a near-complete exit from its holdings in the fintech firm. The transaction involved prominent institutional buyers such as Franklin Templeton, HSBC Mutual Fund, and ICICI Prudential.
- Madison India Capital sold 2.48 crore Pine Labs shares at ₹144 each
- Shares bought by major institutional investors including HSBC Mutual Fund
- Pine Labs posted profitable Q3 with 24% YoY revenue growth
What happened
Madison India Capital, through its Madison India Opportunities IV fund, sold 2.48 crore shares of Pine Labs in a block deal valued at ₹356.86 crore. The shares were sold at ₹144 apiece, a premium of 0.8% over the stock's last closing price, with participation from key institutional investors like Franklin Templeton, HSBC Mutual Fund, ICICI Prudential, Tata Mutual Fund, and Morgan Stanley. Notably, HSBC Mutual Fund acquired the largest portion, buying 61.73 lakh shares for over ₹88 crore.
This transaction nearly completes Madison India Capital's exit from its stake in Pine Labs, which totaled 2.53 crore shares at the end of March 2026. This deal follows a previous partial exit during Pine Labs' IPO last year, where the firm sold part of its holding for a return multiple of 5.6X.
Why it matters
Madison India Capital's near-full exit from Pine Labs comes amid a period of stock price volatility following the expiry of the IPO lock-in period in mid-May 2026, which has seen the share price dip to recent lows. Despite these market fluctuations, Pine Labs continues to demonstrate strong operational performance and financial health.
The company's Q3 FY26 results highlight a consolidated net profit of ₹42.4 crore, a turnaround from a loss in the previous year’s quarter, alongside a 24% year-on-year increase in operating revenue to ₹744.3 crore. These metrics indicate robust business momentum that could underpin future growth, even as large shareholders adjust their positions.
What to watch next
Investors and market watchers should monitor Pine Labs’ upcoming Q4 FY26 financial results, which will provide further insight into the company’s profitability trajectory and revenue generation amid changing shareholder dynamics. Continued strong earnings could stabilize the share price following recent declines.
Additionally, observing how remaining stakeholders, including major institutional investors, manage their holdings will be crucial for understanding potential impacts on Pine Labs’ market valuation and strategic direction going forward in the competitive fintech landscape.